A novel role for CCR3 in brain T-cell infiltration and cognition in aging
Abstract Targeting immune-mediated, age-related, biology has the potential to be a transformative therapeutic strategy. However, the redundant nature of the multiple cytokines that change with aging requires identification of a master downstream regulator to successfully exert therapeutic efficacy. Here, we discovered CCR3 as a prime candidate, and inhibition of CCR3 has profound pro-cognitive benefits, but these benefits are not driven by an obvious direct action on CNS-resident cells. Instead, CCR3-expressing cells in the periphery that are modulated in aging inhibit infiltration of T cells across the blood-brain barrier and reduce neuroinflammation. The axis of CCR3-expressing peripheral immune cells influencing crosstalk from periphery to brain provides a novel and therapeutically tractable link. These findings indicate the broad therapeutic potential of CCR3 inhibition in a spectrum of neuroinflammatory diseases of aging.